Literature DB >> 26449822

Detection of Epstein-Barr virus genome and latent infection gene expression in normal epithelia, epithelial dysplasia, and squamous cell carcinoma of the oral cavity.

Kentaro Kikuchi1, Yoshihiro Noguchi2, Michelle Wendoline Garcia-Niño de Rivera3, Miyako Hoshino4, Hideaki Sakashita4, Tsutomu Yamada5, Harumi Inoue2, Yuji Miyazaki2, Tadashige Nozaki6, Blanca Silvia González-López3, Fumio Ide2, Kaoru Kusama2.   

Abstract

A relationship between Epstein-Barr virus (EBV) infection and cancer of lymphoid and epithelial tissues such as Burkitt's lymphoma, Hodgkin's disease, nasopharyngeal carcinoma (NPC), gastric carcinoma, and oral cancer has been reported. EBV is transmitted orally and infects B cells and epithelial cells. However, it has remained uncertain whether EBV plays a role in carcinogenesis of oral mucosal tissue. In the present study, we detected the EBV genome and latent EBV gene expression in normal mucosal epithelia, epithelial dysplasia, and oral squamous cell carcinoma (OSCC) to clarify whether EBV is involved in carcinogenesis of the oral cavity. We examined 333 formalin-fixed, paraffin-embedded tissue samples (morphologically normal oral mucosa 30 samples, gingivitis 32, tonsillitis 17, oral epithelial dysplasia 83, OSCC 150, and NPC 21). EBV latent infection genes (EBNA-2, LMP-1) were detected not only in OSCC (50.2 %, 10.7 %) but also in severe epithelial dysplasia (66.7 %, 44.4 %), mild to moderate epithelial dysplasia (43.1 %, 18.5 %), gingivitis (78.1 %, 21.9 %), and normal mucosa (83.3 %, 23.3 %). Furthermore, the intensity of EBV latent infection gene expression (EBER, LMP-1) was significantly higher in severe epithelial dysplasia (94.4 %, 72.2 %) than in OSCC (34.7 %, 38.7 %). These results suggest that EBV latent infection genes and their increased expression in severe epithelial dysplasia might play an important role in the dysplasia-carcinoma sequence in the oral cavity.

Entities:  

Keywords:  EBV-determinated nuclear antigen-2 (EBNA-2); EBV-encoded small RNA (EBER); Epstein-Barr virus (EBV); Latent membrane protein-1 (LMP-1); Oral squamous cell carcinoma (OSCC)

Mesh:

Substances:

Year:  2015        PMID: 26449822     DOI: 10.1007/s13277-015-4167-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  69 in total

1.  Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome.

Authors:  M Shirakata; K I Imadome; K Hirai
Journal:  Virology       Date:  1999-10-10       Impact factor: 3.616

2.  Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.

Authors:  Anak Iamaroon; Udomrat Khemaleelakul; Surawut Pongsiriwet; Jarupan Pintong
Journal:  J Oral Pathol Med       Date:  2004-01       Impact factor: 4.253

3.  Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.

Authors:  N Shimizu; A Tanabe-Tochikura; Y Kuroiwa; K Takada
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

4.  Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

Authors:  F Wang; C D Gregory; M Rowe; A B Rickinson; D Wang; M Birkenbach; H Kikutani; T Kishimoto; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Epstein-Barr virus in breast carcinoma in Argentina.

Authors:  María Victoria Preciado; Paola Andrea Chabay; Elena Noemí De Matteo; Pedro Gonzalez; Saúl Grinstein; Andrea Actis; Hugo Daniel Gass
Journal:  Arch Pathol Lab Med       Date:  2005-03       Impact factor: 5.534

6.  LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.

Authors:  N J Thornburg; W Kulwichit; R H Edwards; K H Y Shair; K M Bendt; N Raab-Traub
Journal:  Oncogene       Date:  2006-01-12       Impact factor: 9.867

7.  Epstein-Barr virus in gastric carcinoma.

Authors:  M Tokunaga; C E Land; Y Uemura; T Tokudome; S Tanaka; E Sato
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

8.  STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro.

Authors:  Vivian Wai Yan Lui; Elaine Yue Ling Wong; Yeung Ho; Bo Hong; Sze Chuen Cesar Wong; Qian Tao; Gigi Ching Gee Choi; Thomas Chi Chuen Au; Kakiu Ho; Daisy Mei Sze Yau; Brigette Buig Yue Ma; Edwin Pun Hui; Andrew Sai-Kit Chan; Chi-Man Tsang; Sai-Wah Tsao; Jennifer Rubin Grandis; Anthony Tak-Cheung Chan
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

Review 9.  Host genetics of Epstein-Barr virus infection, latency and disease.

Authors:  Charlotte J Houldcroft; Paul Kellam
Journal:  Rev Med Virol       Date:  2014-11-27       Impact factor: 6.989

10.  Association of Epstein-Barr virus infection and breast carcinoma.

Authors:  Mohamad Nidal Khabaz
Journal:  Arch Med Sci       Date:  2013-08-29       Impact factor: 3.318

View more
  22 in total

Review 1.  Epstein-Barr virus in the pathogenesis of oral cancers.

Authors:  J T Guidry; C E Birdwell; R S Scott
Journal:  Oral Dis       Date:  2017-04-18       Impact factor: 3.511

Review 2.  The interaction between human papillomavirus and other viruses.

Authors:  J T Guidry; R S Scott
Journal:  Virus Res       Date:  2016-11-05       Impact factor: 3.303

3.  Epstein-Barr Virus Detection and LMP-1 Expression in Thai Patients with Oral Squamous Cell Carcinoma.

Authors:  Dulyapong Rungraungrayabkul; Puangwan Lapthanasupkul; Nakarin Kitkumthorn; Jintana Pankam; Boworn Klongnoi; Siribang-On Piboonniyom Khovidhunkit
Journal:  Head Neck Pathol       Date:  2022-10-18

4.  Can Epstein-Barr virus play a role in upper urinary tract urothelial carcinomas?

Authors:  Y Dere; S Ekmekçi; İ Akarken; Ü Küçük
Journal:  Ann R Coll Surg Engl       Date:  2020-06-15       Impact factor: 1.891

Review 5.  Emerging and re-emerging infectious disease in otorhinolaryngology.

Authors:  F Scasso; G Ferrari; G C DE Vincentiis; A Arosio; S Bottero; M Carretti; A Ciardo; S Cocuzza; A Colombo; B Conti; A Cordone; M DE Ciccio; E Delehaye; L Della Vecchia; I DE Macina; C Dentone; P DI Mauro; R Dorati; R Fazio; A Ferrari; G Ferrea; S Giannantonio; I Genta; M Giuliani; D Lucidi; L Maiolino; G Marini; P Marsella; D Meucci; T Modena; B Montemurri; A Odone; S Palma; M L Panatta; M Piemonte; P Pisani; S Pisani; L Prioglio; A Scorpecci; L Scotto DI Santillo; A Serra; C Signorelli; E Sitzia; M L Tropiano; M Trozzi; F M Tucci; L Vezzosi; B Viaggi
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-04       Impact factor: 2.124

Review 6.  Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer.

Authors:  Francisco Aguayo; Enrique Boccardo; Alejandro Corvalán; Gloria M Calaf; Rancés Blanco
Journal:  Infect Agent Cancer       Date:  2021-06-30       Impact factor: 2.965

7.  No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue.

Authors:  Torben Wilms; Gulfaraz Khan; Philip J Coates; Nicola Sgaramella; Robin Fåhraeus; Asma Hassani; Pretty S Philip; Lena Norberg Spaak; Luigi Califano; Giuseppe Colella; Katarina Olofsson; Christos Loizou; Renato Franco; Karin Nylander
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

8.  Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer.

Authors:  Sylwia Fołtyn; Małgorzata Strycharz-Dudziak; Bartłomiej Drop; Anastazja Boguszewska; Małgorzata Polz-Dacewicz
Journal:  Infect Agent Cancer       Date:  2017-05-30       Impact factor: 2.965

9.  Wogonin as a targeted therapeutic agent for EBV (+) lymphoma cells involved in LMP1/NF-κB/miR-155/PU.1 pathway.

Authors:  Xue Wu; Ping Liu; Haijun Zhang; Yuan Li; Jumah Masoud Mohammad Salmani; Fei Wang; Ke Yang; Rong Fu; Zhewei Chen; Baoan Chen
Journal:  BMC Cancer       Date:  2017-02-21       Impact factor: 4.430

Review 10.  Epstein-Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity.

Authors:  Kentaro Kikuchi; Harumi Inoue; Yuji Miyazaki; Fumio Ide; Masaru Kojima; Kaoru Kusama
Journal:  Jpn Dent Sci Rev       Date:  2017-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.